BEAM
Price
$20.16
Change
+$0.29 (+1.46%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
1.92B
19 days until earnings call
SCPH
Price
$2.49
Change
-$0.11 (-4.23%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
131.24M
26 days until earnings call
Ad is loading...

BEAM vs SCPH

Header iconBEAM vs SCPH Comparison
Open Charts BEAM vs SCPHBanner chart's image
Beam Therapeutics
Price$20.16
Change+$0.29 (+1.46%)
Volume$40.21K
Capitalization1.92B
scPharmaceuticals
Price$2.49
Change-$0.11 (-4.23%)
Volume$5.32K
Capitalization131.24M
BEAM vs SCPH Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. SCPH commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and SCPH is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (BEAM: $19.87 vs. SCPH: $2.59)
Brand notoriety: BEAM and SCPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 84% vs. SCPH: 36%
Market capitalization -- BEAM: $1.92B vs. SCPH: $131.24M
BEAM [@Biotechnology] is valued at $1.92B. SCPH’s [@Biotechnology] market capitalization is $131.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileSCPH’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • SCPH’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than SCPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while SCPH’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • SCPH’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SCPH is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +19.55% price change this week, while SCPH (@Biotechnology) price change was +1.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

SCPH is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.92B) has a higher market cap than SCPH($131M). BEAM YTD gains are higher at: -19.879 vs. SCPH (-26.836). SCPH has higher annual earnings (EBITDA): -71.31M vs. BEAM (-383.98M). BEAM has more cash in the bank: 851M vs. SCPH (91.5M). SCPH has less debt than BEAM: SCPH (52.5M) vs BEAM (161M). BEAM has higher revenues than SCPH: BEAM (63.5M) vs SCPH (30.3M).
BEAMSCPHBEAM / SCPH
Capitalization1.92B131M1,469%
EBITDA-383.98M-71.31M538%
Gain YTD-19.879-26.83674%
P/E RatioN/AN/A-
Revenue63.5M30.3M210%
Total Cash851M91.5M930%
Total Debt161M52.5M307%
FUNDAMENTALS RATINGS
SCPH: Fundamental Ratings
SCPH
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMSCPH
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 10 days ago
77%
Declines
ODDS (%)
Bearish Trend 21 days ago
85%
Bearish Trend 24 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGEWX8.820.18
+2.08%
Baillie Gifford Emer Mkt Ex Chn Instl
IENIX28.50N/A
N/A
Invesco Energy R5
SFSLX24.51N/A
N/A
1919 Financial Services C
CPODX42.22N/A
N/A
Morgan Stanley Insight I
BROAX20.08N/A
N/A
BlackRock Advantage International Inv A